{"id":"https://openalex.org/W2136123330","doi":"https://doi.org/10.1186/s40780-015-0015-6","title":"Hyperglycemic adverse events following antipsychotic drug administration in spontaneous adverse event reports","display_name":"Hyperglycemic adverse events following antipsychotic drug administration in spontaneous adverse event reports","publication_year":2015,"publication_date":"2015-04-09","ids":{"openalex":"https://openalex.org/W2136123330","doi":"https://doi.org/10.1186/s40780-015-0015-6","mag":"2136123330","pmid":"https://pubmed.ncbi.nlm.nih.gov/26819726","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/4728749"},"language":"en","primary_location":{"id":"doi:10.1186/s40780-015-0015-6","doi":"https://doi.org/10.1186/s40780-015-0015-6","is_oa":true,"landing_page_url":"https://doi.org/10.1186/s40780-015-0015-6","pdf_url":"https://jphcs.biomedcentral.com/track/pdf/10.1186/s40780-015-0015-6","source":{"id":"https://openalex.org/S2737624436","display_name":"Journal of Pharmaceutical Health Care and Sciences","issn_l":"2055-0294","issn":["2055-0294"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-d","oarl","poland-40","russia-white-list-3"],"host_organization":"https://openalex.org/P4310320256","host_organization_name":"BioMed Central","host_organization_lineage":["https://openalex.org/P4310320256","https://openalex.org/P4310319965"],"host_organization_lineage_names":["BioMed Central","Springer Nature"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Pharmaceutical Health Care and Sciences","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","doaj","pubmed"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://jphcs.biomedcentral.com/track/pdf/10.1186/s40780-015-0015-6","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5059305205","display_name":"Yamato Kato","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I173865709","display_name":"Gifu Pharmaceutical University","ror":"https://ror.org/0372t5741","country_code":"JP","type":"education","lineage":["https://openalex.org/I173865709"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Yamato Kato","raw_affiliation_strings":["Laboratory of Drug Informatics, Gifu Pharmaceutical University, 1-25-4, Daigaku-Nishi, Gifu, 501-1196 Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Laboratory of Drug Informatics, Gifu Pharmaceutical University, 1-25-4, Daigaku-Nishi, Gifu, 501-1196 Japan","institution_ids":["https://openalex.org/I173865709"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5006623335","display_name":"Ryogo Umetsu","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I173865709","display_name":"Gifu Pharmaceutical University","ror":"https://ror.org/0372t5741","country_code":"JP","type":"education","lineage":["https://openalex.org/I173865709"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Ryogo Umetsu","raw_affiliation_strings":["Laboratory of Drug Informatics, Gifu Pharmaceutical University, 1-25-4, Daigaku-Nishi, Gifu, 501-1196 Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Laboratory of Drug Informatics, Gifu Pharmaceutical University, 1-25-4, Daigaku-Nishi, Gifu, 501-1196 Japan","institution_ids":["https://openalex.org/I173865709"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5046361104","display_name":"Junko Abe","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I173865709","display_name":"Gifu Pharmaceutical University","ror":"https://ror.org/0372t5741","country_code":"JP","type":"education","lineage":["https://openalex.org/I173865709"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Junko Abe","raw_affiliation_strings":["Laboratory of Drug Informatics, Gifu Pharmaceutical University, 1-25-4, Daigaku-Nishi, Gifu, 501-1196 Japan ; Medical Database Co., LTD, 3-11-10, Higashi, Sibuya Ward, Tokyo, 150-0011 Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Laboratory of Drug Informatics, Gifu Pharmaceutical University, 1-25-4, Daigaku-Nishi, Gifu, 501-1196 Japan ; Medical Database Co., LTD, 3-11-10, Higashi, Sibuya Ward, Tokyo, 150-0011 Japan","institution_ids":["https://openalex.org/I173865709"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5112545952","display_name":"Natsumi Ueda","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I173865709","display_name":"Gifu Pharmaceutical University","ror":"https://ror.org/0372t5741","country_code":"JP","type":"education","lineage":["https://openalex.org/I173865709"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Natsumi Ueda","raw_affiliation_strings":["Laboratory of Drug Informatics, Gifu Pharmaceutical University, 1-25-4, Daigaku-Nishi, Gifu, 501-1196 Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Laboratory of Drug Informatics, Gifu Pharmaceutical University, 1-25-4, Daigaku-Nishi, Gifu, 501-1196 Japan","institution_ids":["https://openalex.org/I173865709"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5000988655","display_name":"Y\u00f4ko Nakayama","orcid":"https://orcid.org/0000-0001-8778-4415","observed_orcids":["https://orcid.org/0000-0001-8778-4415"]},"institutions":[{"id":"https://openalex.org/I173865709","display_name":"Gifu Pharmaceutical University","ror":"https://ror.org/0372t5741","country_code":"JP","type":"education","lineage":["https://openalex.org/I173865709"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Yoko Nakayama","raw_affiliation_strings":["Laboratory of Drug Informatics, Gifu Pharmaceutical University, 1-25-4, Daigaku-Nishi, Gifu, 501-1196 Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Laboratory of Drug Informatics, Gifu Pharmaceutical University, 1-25-4, Daigaku-Nishi, Gifu, 501-1196 Japan","institution_ids":["https://openalex.org/I173865709"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5113532331","display_name":"Yasutomi Kinosada","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I42405503","display_name":"Gifu University","ror":"https://ror.org/024exxj48","country_code":"JP","type":"education","lineage":["https://openalex.org/I42405503"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Yasutomi Kinosada","raw_affiliation_strings":["Department of Biomedical Informatics, Gifu University Graduate School of Medicine, 1-1 Yanagido, Gifu, 501-1196 Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Biomedical Informatics, Gifu University Graduate School of Medicine, 1-1 Yanagido, Gifu, 501-1196 Japan","institution_ids":["https://openalex.org/I42405503"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5055962201","display_name":"Mitsuhiro Nakamura","orcid":"https://orcid.org/0000-0002-5062-5522","observed_orcids":["https://orcid.org/0000-0002-5062-5522"]},"institutions":[{"id":"https://openalex.org/I173865709","display_name":"Gifu Pharmaceutical University","ror":"https://ror.org/0372t5741","country_code":"JP","type":"education","lineage":["https://openalex.org/I173865709"]}],"countries":["JP"],"is_corresponding":true,"raw_author_name":"Mitsuhiro Nakamura","raw_affiliation_strings":["Laboratory of Drug Informatics, Gifu Pharmaceutical University, 1-25-4, Daigaku-Nishi, Gifu, 501-1196 Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Laboratory of Drug Informatics, Gifu Pharmaceutical University, 1-25-4, Daigaku-Nishi, Gifu, 501-1196 Japan","institution_ids":["https://openalex.org/I173865709"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":["https://openalex.org/A5055962201"],"corresponding_institution_ids":["https://openalex.org/I173865709"],"apc_list":{"value":2490,"currency":"USD","value_usd":2490},"apc_paid":{"value":2490,"currency":"USD","value_usd":2490},"fwci":2.75,"has_fulltext":true,"cited_by_count":34,"citation_normalized_percentile":{"value":0.88721295,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":87,"max":98},"biblio":{"volume":"1","issue":"1","first_page":"15","last_page":"15"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10023","display_name":"Schizophrenia research and treatment","score":0.6205999851226807,"subfield":{"id":"https://openalex.org/subfields/2738","display_name":"Psychiatry and Mental health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10023","display_name":"Schizophrenia research and treatment","score":0.6205999851226807,"subfield":{"id":"https://openalex.org/subfields/2738","display_name":"Psychiatry and Mental health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11943","display_name":"Pharmacovigilance and Adverse Drug Reactions","score":0.3732999861240387,"subfield":{"id":"https://openalex.org/subfields/3005","display_name":"Toxicology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10854","display_name":"Bipolar Disorder and Treatment","score":0.00039999998989515007,"subfield":{"id":"https://openalex.org/subfields/2738","display_name":"Psychiatry and Mental health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/antipsychotic-drugs","display_name":"antipsychotic drugs","score":0.8849999904632568},{"id":"https://openalex.org/keywords/hyperglycemia","display_name":"hyperglycemia","score":0.9649999737739563},{"id":"https://openalex.org/keywords/adverse-drug-reactions","display_name":"adverse drug reactions","score":0.9509999752044678},{"id":"https://openalex.org/keywords/atypical-antipsychotics","display_name":"atypical antipsychotics","score":0.9210000038146973},{"id":"https://openalex.org/keywords/polypharmacy","display_name":"polypharmacy","score":0.765999972820282},{"id":"https://openalex.org/keywords/quetiapine","display_name":"quetiapine","score":0.9359999895095825},{"id":"https://openalex.org/keywords/olanzapine","display_name":"olanzapine","score":1.0},{"id":"https://openalex.org/keywords/risperidone","display_name":"risperidone","score":0.9819999933242798},{"id":"https://openalex.org/keywords/aripiprazole","display_name":"aripiprazole","score":0.9700000286102295},{"id":"https://openalex.org/keywords/haloperidol","display_name":"haloperidol","score":0.8930000066757202},{"id":"https://openalex.org/keywords/clozapine","display_name":"clozapine","score":1.0},{"id":"https://openalex.org/keywords/prochlorperazine","display_name":"prochlorperazine","score":0.9739999771118164},{"id":"https://openalex.org/keywords/chlorpromazine","display_name":"chlorpromazine","score":0.996999979019165},{"id":"https://openalex.org/keywords/fda-adverse-event-reporting-system","display_name":"FDA Adverse Event Reporting System","score":0.8700000047683716},{"id":"https://openalex.org/keywords/signal-strength","display_name":"signal strength","score":0.578000009059906},{"id":"https://openalex.org/keywords/drug-safety","display_name":"drug safety","score":0.5569999814033508}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.9297643899917603},{"id":"https://openalex.org/C197934379","wikidata":"https://www.wikidata.org/wiki/Q2047938","display_name":"Adverse effect","level":2,"score":0.8194140195846558},{"id":"https://openalex.org/C2777105317","wikidata":"https://www.wikidata.org/wiki/Q4686710","display_name":"Adverse Event Reporting System","level":3,"score":0.5811368823051453},{"id":"https://openalex.org/C2780494398","wikidata":"https://www.wikidata.org/wiki/Q208144","display_name":"Antipsychotic","level":3,"score":0.546248197555542},{"id":"https://openalex.org/C2780035454","wikidata":"https://www.wikidata.org/wiki/Q8386","display_name":"Drug","level":2,"score":0.4927263557910919},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.478549063205719},{"id":"https://openalex.org/C104863432","wikidata":"https://www.wikidata.org/wiki/Q614304","display_name":"Pharmacy","level":2,"score":0.4454967975616455},{"id":"https://openalex.org/C2780542314","wikidata":"https://www.wikidata.org/wiki/Q45959","display_name":"Adverse drug reaction","level":3,"score":0.42244553565979004},{"id":"https://openalex.org/C42219234","wikidata":"https://www.wikidata.org/wiki/Q131130","display_name":"Anesthesia","level":1,"score":0.37420517206192017},{"id":"https://openalex.org/C177713679","wikidata":"https://www.wikidata.org/wiki/Q679690","display_name":"Intensive care medicine","level":1,"score":0.35616254806518555},{"id":"https://openalex.org/C118552586","wikidata":"https://www.wikidata.org/wiki/Q7867","display_name":"Psychiatry","level":1,"score":0.27952516078948975},{"id":"https://openalex.org/C2776412080","wikidata":"https://www.wikidata.org/wiki/Q7431605","display_name":"Schizophrenia (object-oriented programming)","level":2,"score":0.22338548302650452},{"id":"https://openalex.org/C512399662","wikidata":"https://www.wikidata.org/wiki/Q3505712","display_name":"Family medicine","level":1,"score":0.08703958988189697}],"mesh":[],"locations_count":3,"locations":[{"id":"doi:10.1186/s40780-015-0015-6","doi":"https://doi.org/10.1186/s40780-015-0015-6","is_oa":true,"landing_page_url":"https://doi.org/10.1186/s40780-015-0015-6","pdf_url":"https://jphcs.biomedcentral.com/track/pdf/10.1186/s40780-015-0015-6","source":{"id":"https://openalex.org/S2737624436","display_name":"Journal of Pharmaceutical Health Care and Sciences","issn_l":"2055-0294","issn":["2055-0294"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-d","oarl","poland-40","russia-white-list-3"],"host_organization":"https://openalex.org/P4310320256","host_organization_name":"BioMed Central","host_organization_lineage":["https://openalex.org/P4310320256","https://openalex.org/P4310319965"],"host_organization_lineage_names":["BioMed Central","Springer Nature"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Pharmaceutical Health Care and Sciences","raw_type":"journal-article"},{"id":"pmid:26819726","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/26819726","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of pharmaceutical health care and sciences","raw_type":"Journal Article"},{"id":"pmh:oai:pubmedcentral.nih.gov:4728749","doi":null,"is_oa":true,"landing_page_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC4728749/","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"J Pharm Health Care Sci","raw_type":"Text"}],"best_oa_location":{"id":"doi:10.1186/s40780-015-0015-6","doi":"https://doi.org/10.1186/s40780-015-0015-6","is_oa":true,"landing_page_url":"https://doi.org/10.1186/s40780-015-0015-6","pdf_url":"https://jphcs.biomedcentral.com/track/pdf/10.1186/s40780-015-0015-6","source":{"id":"https://openalex.org/S2737624436","display_name":"Journal of Pharmaceutical Health Care and Sciences","issn_l":"2055-0294","issn":["2055-0294"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-d","oarl","poland-40","russia-white-list-3"],"host_organization":"https://openalex.org/P4310320256","host_organization_name":"BioMed Central","host_organization_lineage":["https://openalex.org/P4310320256","https://openalex.org/P4310319965"],"host_organization_lineage_names":["BioMed Central","Springer Nature"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Pharmaceutical Health Care and Sciences","raw_type":"journal-article"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":1.0,"display_name":"Good health and well-being"}],"study_designs":[{"id":"https://openalex.org/study-designs/observational-study","display_name":"Observational Study"}],"awards":[{"id":"https://openalex.org/G2595741700","display_name":"On Development of Assisting System for Appropriate Use of Drugs and Fostering of Advanced Clinical Human Resources","funder_award_id":"24390126","funder_id":"https://openalex.org/F4320334764","funder_display_name":"Japan Society for the Promotion of Science"}],"funders":[{"id":"https://openalex.org/F4320334764","display_name":"Japan Society for the Promotion of Science","ror":"https://ror.org/00hhkn466"}],"has_content":{"pdf":true,"grobid_xml":true},"content_urls":{"pdf":"https://content.openalex.org/works/W2136123330.pdf","grobid_xml":"https://content.openalex.org/works/W2136123330.grobid-xml"},"referenced_works_count":20,"referenced_works":["https://openalex.org/W100441917","https://openalex.org/W1518499126","https://openalex.org/W1606742910","https://openalex.org/W1712554668","https://openalex.org/W1980945745","https://openalex.org/W2009405599","https://openalex.org/W2052733264","https://openalex.org/W2064716383","https://openalex.org/W2074289946","https://openalex.org/W2107625293","https://openalex.org/W2109196233","https://openalex.org/W2119971225","https://openalex.org/W2120604806","https://openalex.org/W2126642792","https://openalex.org/W2151931639","https://openalex.org/W2159155203","https://openalex.org/W2166256285","https://openalex.org/W2166685434","https://openalex.org/W2170182304","https://openalex.org/W4243610639"],"related_works":["https://openalex.org/W2409457278","https://openalex.org/W7160406163","https://openalex.org/W138065952","https://openalex.org/W2017353106","https://openalex.org/W1997822118","https://openalex.org/W2045824499","https://openalex.org/W7154959484","https://openalex.org/W6907402998","https://openalex.org/W100441917","https://openalex.org/W1963992314"],"abstract_inverted_index":{"BACKGROUND:":[0],"Antipsychotics":[1],"are":[2,53,196],"potent":[3],"dopamine":[4],"antagonists":[5],"used":[6,92],"to":[7,19,76,93],"treat":[8],"schizophrenia":[9],"and":[10,26,117,134,164,177],"bipolar":[11],"disorder.":[12],"The":[13,79,98,138],"aim":[14],"of":[15,60,100,144,155,188],"this":[16],"study":[17],"was":[18,91,119],"evaluate":[20],"the":[21,31,70,105,185,189],"relationship":[22],"between":[23],"antipsychotic":[24,50,67,108,146],"drugs":[25,68],"adverse":[27,44,61,95,101,150],"hyperglycemic":[28,45,62,96,102,151],"events":[29,46,63,152],"using":[30],"FDA":[32],"Adverse":[33],"Event":[34],"Reporting":[35],"System":[36],"(FAERS)":[37],"database.":[38],"In":[39],"particular,":[40],"we":[41],"focused":[42],"on":[43],"associated":[47,64,180],"with":[48,65,142,181],"atypical":[49],"use,":[51],"which":[52],"major":[54],"concerns.":[55],"FINDINGS:":[56],"We":[57],"analyzed":[58],"reports":[59,103,156],"26":[66],"in":[69],"FAERS":[71],"database":[72],"from":[73],"January":[74],"2004":[75],"March":[77],"2013.":[78],"Standardized":[80],"Medical":[81],"Dictionary":[82],"for":[83,104,157,161,166],"Regulatory":[84],"Activities":[85],"Queries":[86],"(SMQ)":[87],"preferred":[88],"terms":[89],"(PTs)":[90],"identify":[94],"events.":[97],"number":[99],"top":[106],"eight":[107],"drugs,":[109],"quetiapine,":[110],"olanzapine,":[111],"risperidone,":[112],"aripiprazole,":[113],"haloperidol,":[114],"clozapine,":[115],"prochlorperazine,":[116],"chlorpromazine":[118],"12,471":[120],"(28.9%),":[121],"8,423":[122],"(37.9%),":[123],"5,968":[124],"(27.0%),":[125],"4,045":[126],"(23.7%),":[127],"3,445":[128],"(31.5%),":[129],"2,614":[130],"(14.3%),":[131],"1,800":[132],"(19.8%),":[133],"1,003":[135],"(35.7%),":[136],"respectively.":[137],"reporting":[139],"ratio":[140],"increased":[141],"co-administration":[143],"multiple":[145],"drugs.":[147],"For":[148],"example,":[149],"represented":[153],"21.6%":[154],"quetiapine":[158],"monotherapy,":[159],"39.9%":[160],"two-drug":[162],"polypharmacy,":[163],"66.3%":[165],"three-drug":[167],"polypharmacy.":[168],"CONCLUSION:":[169],"Antipsychotic":[170],"drug":[171],"polypharmacy":[172],"may":[173,178],"influence":[174],"signal":[175],"strength,":[176],"be":[179],"hyperglycemia.":[182],"After":[183],"considering":[184],"causality":[186],"restraints":[187],"current":[190],"analysis,":[191],"further":[192],"robust":[193],"epidemiological":[194],"studies":[195],"recommended.":[197]},"counts_by_year":[{"year":2025,"cited_by_count":2},{"year":2024,"cited_by_count":2},{"year":2023,"cited_by_count":1},{"year":2022,"cited_by_count":3},{"year":2021,"cited_by_count":6},{"year":2020,"cited_by_count":3},{"year":2019,"cited_by_count":4},{"year":2018,"cited_by_count":3},{"year":2017,"cited_by_count":4},{"year":2016,"cited_by_count":5},{"year":2015,"cited_by_count":1}],"updated_date":"2026-11-10T11:39:43.021295","created_date":"2016-06-24T00:00:00"}